Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China.
about
Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspectiveA systematically combined genotype and functional combination analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in different geographic areas of mainland China--a basis for personalized therapyPharmacogenetics of CYP2C19: functional and clinical implications of a new variant CYP2C19*17Impact of the CYP2C19*17 allele on the pharmacokinetics of omeprazole and pantoprazole in children: evidence for a differential effect.Association of CYP2C19*2 and *3 genetic variants with essential hypertension in KoreansNovel DNA sequence variations of cytochrome P450 genes in the Han Chinese population.Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis.Implementation of Cell Samples as Controls in National Proficiency Testing for Clopidogrel Therapy-Related CYP2C19 Genotyping in China: A Novel Approach.Impact of CYP2C19 Variants on Clinical Efficacy of Clopidogrel and 1-Year Clinical Outcomes in Coronary Heart Patients Undergoing Percutaneous Coronary Intervention.Genetic polymorphisms and phenotypic analysis of drug-metabolizing enzyme CYP2C19 in a Li Chinese population.Genotype and allele frequency of CYP2C19*17 in a healthy Iranian populationClinical Application of CYP2C19 Pharmacogenetics Toward More Personalized MedicineGenotype‑phenotype analysis of CYP2C19 in the Tibetan population and its potential clinical implications in drug therapyNon-Carriers of Reduced-Function CYP2C19 Alleles are Most Susceptible to Impairment of the Anti-Platelet Effect of Clopidogrel by Proton-Pump Inhibitors: A Pilot Study.Association study between FSHR Ala307Thr and Ser680Asn variants and polycystic ovary syndrome (PCOS) in Northern Chinese Han women.Establishment and application of a real-time loop-mediated isothermal amplification system for the detection of CYP2C19 polymorphisms.Genotype-phenotype analysis of CYP2C19 in healthy saudi individuals and its potential clinical implication in drug therapy.Potent and Orally Bioavailable Antiplatelet Agent, PLD-301, with the Potential of Overcoming Clopidogrel ResistanceAfrican Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development.Lipid-lowing pharmacogenomics in Chinese patients.Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations.In vitro functional analysis of 24 novel CYP2C19 variants recently found in the Chinese Han population.Genetic polymorphisms of the drug-metabolizing enzyme CYP2C19 in the Uyghur population in northwest China.Characterization of the genetic profile of CYP2C19 in two South African populations.The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder.Association study of UGT1A9 promoter polymorphisms with DILI based on systematically regional variation screen in Chinese population.Feasibility of a microarray-based point-of-care CYP2C19 genotyping test for predicting clopidogrel on-treatment platelet reactivityFrequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland Chinese Kazakh, Uygur and Han populations.Pharmacokinetics and bioavailability comparison of generic and branded citalopram 20 mg tablets: an open-label, randomized-sequence, two-period crossover study in healthy Chinese CYP2C19 extensive metabolizers.Genetic polymorphisms and novel allelic variants of CYP2C19 in the Chinese Han population.Analysis of the CYP2C19 genotype associated with bleeding in Serbian STEMI patients who have undergone primary PCI and treatment with clopidogrel.Impact of Diabetes Mellitus on Percutaneous Coronary Intervention Outcomes: Real-World Lessons From a Large Chinese Single-Center Registry.Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (‑806 C>T) alleles among an Iranian population of different ethnicities.Effects of cytochrome P450 3A4 and non-genetic factors on initial voriconazole serum trough concentrations in hematological patients with different cytochrome P450 2C19 genotypes.Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations.Association of rs2254638 Polymorphism With Clopidogrel Response in Chinese Patients With Coronary Artery DiseaseGenetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han ChineseThe effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro
P2860
Q27009221-F6AC8565-C49F-4E72-825A-6350FD26BF3AQ28533992-75CCA3DF-9F24-4F8A-942D-D55E7DFB3F7DQ33692784-1C2A13C1-BAB5-43F8-91A3-67E15F83A5B4Q33891049-39C5B6E5-A908-4833-8269-368CC972ED4BQ34306561-B445A559-6037-4201-A6EC-14F3CD24A199Q34963630-F4F134A8-2FA2-491E-AD2C-9356795E8863Q35086962-8203CAB7-FD60-4E51-99C4-865F9886E115Q35719554-FE9EB10B-EC9F-4658-9C66-4FA5B34FDF92Q36216896-6E2F6624-C28A-47AE-A362-6DA689315553Q36375369-37795C4F-4D60-490D-B98D-30EF2EBFA150Q36469405-B4F9A53B-C4A5-47EE-AE07-A1124BB72742Q36580034-4DD5EAB6-5E65-447F-A433-01B695DF52ABQ36624080-4925F5ED-4D1C-4E13-A57A-705F1405E2DCQ36754362-195BC0D0-98B0-4EBB-BDE6-2B8A65F83CF0Q36875046-29DF6036-D35C-4931-98D7-488C4EC92E51Q36953706-59A5668A-3FAC-46B4-9D34-6E7E90E93406Q37176949-7B5C9378-77B3-4CDF-B393-8EAC6707E9EAQ37204050-4163F548-BE85-4AF0-832F-22A2F0736A1FQ37714285-CE7EE1D7-10EA-44F8-A223-782DA275E894Q38129422-AE3E3757-D1B4-4A96-BBAC-D5066CDA27BFQ38616806-FF43139D-A2CA-42AD-8A14-2CB78779EEEFQ38855535-81334BF1-5AE8-4ADF-80C8-7F16DBF2D14AQ38947127-B3481D26-F8DE-4E5D-B9A8-8EF3A269AB7AQ39667176-A3223D23-843F-476E-B6C9-E2C9220FF097Q40569531-EDC4475B-76EF-42C2-AAEC-AD33878E4F22Q41636182-08EE8123-4968-4C20-AD67-299F951BF15AQ42182060-BE3F84B3-0B22-4D43-B48D-0334DEFC5408Q44035907-49D45D7A-294E-4E19-920A-C035BDC3506EQ44675980-9F2068CC-F979-4C79-8850-17DF522C42DEQ45821926-8B7B5AAA-82D0-4A9D-ACE3-CACEF6615ED5Q47232877-39DF04BB-CCD3-41E4-92BA-9A6E97E0469CQ50052819-8A60F003-C9A6-4499-AFB9-0465A5E9BDA9Q50067945-602639C4-5F7E-4E5C-BEA2-045A25266BDAQ51275882-FDAFEDA3-5949-4D4E-A5E5-04D2CAF67A45Q54349187-A258EF9F-8E23-4924-8D3B-85F0D9A9E65FQ57072916-57419AE7-1BC6-4431-9A05-B343E582702FQ57251500-997565A0-0A0C-47CB-84FE-9DDE05D69604Q59125874-3E1747D1-3B45-4930-B245-778B25C2A0FD
P2860
Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Genetic polymorphism analysis ...... aphic areas of mainland China.
@en
type
label
Genetic polymorphism analysis ...... aphic areas of mainland China.
@en
prefLabel
Genetic polymorphism analysis ...... aphic areas of mainland China.
@en
P2093
P2860
P356
P1433
P1476
Genetic polymorphism analysis ...... raphic areas of mainland China
@en
P2093
Guoyin Feng
Jimin Tang
Lingling Chen
Qinghe Xing
Shengying Qin
P2860
P304
P356
10.2217/14622416.9.6.691
P50
P577
2008-06-01T00:00:00Z